- Home
- TOPS vs SBFM Comparison
TOPS vs SBFM Comparison
Compare TOPS & SBFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOPS | SBFM |
|---|---|---|
| Founded | 2000 | 2006 |
| Country | Greece | United States |
| Employees | N/A | 50 |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2M | 2.2M |
| IPO Year | 2004 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TOPS | SBFM |
|---|---|---|
| Price | $0.30 | $3.33 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 594.9K | ★ 10.3M |
| Earning Date | 09-16-2026 | 11-12-2026 |
| Dividend Yield | ★ 287.62% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $36,305,891.00 |
| Revenue This Year | N/A | $1.23 |
| Revenue Next Year | N/A | $22.44 |
| P/E Ratio | $2.14 | ★ N/A |
| Revenue Growth | N/A | ★ 4.11 |
| 52 Week Low | $0.27 | $0.13 |
| 52 Week High | $7.40 | $18.50 |
Technical Indicators
Market Signals| Indicator | TOPS | SBFM |
|---|---|---|
| Relative Strength Index (RSI) | 22.20 | 87.31 |
| Support Level | N/A | $1.06 |
| Resistance Level | $1.29 | $13.50 |
| Average True Range (ATR) | 0.04 | 0.17 |
| MACD | -0.01 | 0.39 |
| Stochastic Oscillator | 10.24 | 98.64 |
Price Performance
Historical ComparisonAbout TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco-tanker vessels, focusing on the transportation of crude oil, petroleum products (both clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements. The company operates in two reportable segments: (i) the tanker segment and (ii) the megayacht segment.
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.